Clarivate closes $600M sale of Life Sciences & Healthcare to Altaris; segment head Levy departs

CLARIVATE PLC

Deal consideration: $500M cash at closing plus a $75M unsecured senior note from an Altaris affiliate and $25M deferred cash payable by January 31, 2028.
Henry Levy, President, Life Sciences & Healthcare, terminated employment at closing; separation agreement follows the retention agreement disclosed July 6, 2026.
Clarivate will use proceeds to reduce debt; remaining portfolio is Academia & Government (Web of Science, ProQuest, Alma, Vega) and Intellectual Property (IPOne, Derwent, CompuMark, IPfolio).
Q3 2026 results are set for November 3, 2026, when Clarivate will update full-year 2026 guidance to reflect the divestiture.
Pro forma condensed balance sheet as of June 30, 2026 and statements of operations for 2023-2025 and 1H26 to be filed by October 13, 2026.

item 2.01 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Henry Levy

President, Life Sciences & Healthcare

CLVT · CLARIVATE PLC

Filed: October 6, 2026, 4:29 PM ET

Upon the Closing and in connection with the Transaction, Henry Levy, Clarivate’s President, Life Sciences & Healthcare, terminated employment with a subsidiary of Clarivate.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Henry Levy departed as President, Life Sciences & Healthcare at CLARIVATE PLC.

Action: terminated employment
Role: President, Life Sciences & Healthcare

Exact text from the filing

Upon the Closing and in connection with the Transaction, Henry Levy, Clarivate’s President, Life Sciences & Healthcare, terminated employment with a subsidiary of Clarivate.

View on SEC.gov

CLARIVATE PLC filing history →

Source: SEC EDGAR

accession 0001764046-26-000117

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.